Heading to #ASHI2025? 🌴
Visit @iMDxInc 311!
🎤 Symposium: GraftAssureIQ – Enabling In-House dd-cfDNA Testing in Transplant Research
🗓 Oct 9 | 12:40–1:35 pm ET | Grand Cypress Ballroom A–C
See you there! @ASHIHQ
🔗 Info: 6363663.hs-sites.com/ashi202…
#iMDx
@iMDxInc will showcase GraftAssure™ & GraftAssureIQ™ at @IATDMCT (Singapore, 9/24) + ASHI (Orlando, 10/9). “In-house testing will bring care where it belongs – closer to the patient.” – Josh Riggs, CEO
🔗 investors.imdxinc.com/news-r…
#TransplantInnovation #Transplant #iMDx $IMDX
iMDx to Participate in NYC Investment Conferences Sept. 8 - 11. @iMDxInc, (Nasdaq: IMDX), today announced participation in investor conferences hosted by both H.C. Wainwright and Lake Street Capital Markets.
Click for more: investors.imdxinc.com/news-r…
New data from @iMDxInc shows 78% PPV & 93% NPV for kidney transplant rejection using our combined dd-cfDNA score. Catch our presentation (8/6 @ 10:45am). Visit Booth #324 at #WTC25! 🧬
Read here: hubs.li/Q03zFhms0
#iMDx #ddcfDNA #TransplantInnovation $IMDX
🚀🚨 Join @iMDxInc on Aug 15 for a virtual KOL event with Dr. Langone on dd‑cfDNA in transplant care + GraftAssure™ tech. Learn how in‑house testing is changing the game. Register now! Link to full post here: hubs.li/Q03zcMM50
#transplant #biotech #iMDx $IMDX
🌟 #ESOT2025 is here! 🌟
Heading to the exhibit hall? Don’t forget to stop by Booth D46 to chat with the @iMDxInc team and explore GraftAssureIQ™.
🔗 hubs.li/Q03v3nGX0
#TransplantInnovation #iMDx #GraftAssure
We’re headed to #ESOT2025! Visit @iMDxInc at Booth D46 to explore GraftAssureIQ™.
📅 June 29–July 2 | 📍 London, UK
🔗 hubs.li/Q03v3lsr0
See you there!
#iMDx #TransplantInnovation
Attending ASHI's 2025 Educational Workshop? @iMDxInc is here! Catch Jim Fee on June 27 at 1:15 PM as he presents on Novel Decentralized dd-cfDNA Testing. Let’s connect in Detroit! #ASHI2025 #iMDx #ddcfDNA #TransplantInnovation
@OncocyteCorp is now
@iMDxInc
Inc. — Insight Molecular Diagnostics Inc. 💬 This rebrand “symbolically support[s] our aim to put doctors, laboratory technicians, and researchers at the center of what we do.” – Andrea James Read here: hubs.li/Q03sp0M-0 #iMDx #OCX $OCX
We’re at #ASCO25! Meet the @OncocyteCorp team & check out our latest in cancer diagnostics. Access our online abstracts/presentations via the links in the comments. Let’s shape the future of oncology together. 💡 #Immunotherapy #Innovation #OCX #WhereTomorrowLives $OCX
📄 Don’t miss our online abstracts/presentations -
asco.org/abstracts-presentat…
meetings.asco.org/abstracts-…
🚀 Big news from @Oncocyte! #Medicare has set national pricing for our transplant rejection test—an exciting step toward #FDA clearance and broader adoption. “We believe this reflects the value of our tech,” said CEO Josh Riggs.
Read about it here: hubs.li/Q03ndk4X0
#OCX
In case you missed it — #EFI2025 wrapped up Saturday in beautiful Prague!
We had a great week connecting with laboratory professionals and discussing GraftAssure RUO.
Big congrats to our raffle winners — and thanks to everyone who stopped by Booth #9!
#Transplant #OCX
We’re headed to #EFI2025 in Prague! 🇨🇿 Visit Booth #9 to chat about GraftAssure—our transplant monitoring tool—and enter our #DailyRaffle! 🎟️ #TransplantCare #OCX (@OncocyteCorp)
Big step forward! IRB approved & top U.S. transplant centers joining our trial. “We’re building strong momentum,” said CEO Josh Riggs. Exciting milestones ahead! 🧬
Click here: hubs.li/Q03kqt_v0
@OncocyteCorp
#OCX #clinicalTrials #Transplant #Biotech #WhereTomorrowLIVES






